Ensaio em fase de recrutamento = ; Ensaio a decorrer = ; Financiado por um membro do IRDiRC = ; Membro de uma ERN =

Ensaio (s) clínico (s) nacional (is)

Ensaio (s) clínico (s) multinacional (ais)

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

GENEGRAFT: Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector (Orphan drug designation (EU/3/09/630))

European Commission

DG Research - Directorate General for Research

Mais detalhes

FRANCA

ILE-DE-FRANCE
PARIS

GENEGRAFT: Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector (Orphan drug designation (EU/3/09/630))

Hôpital Necker-Enfants Malades

Service de dermatologie

Mais detalhes